
Citeline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
| Publishes | Daily | Episodes | 549 | Founded | 12 years ago |
|---|---|---|---|---|---|
| Number of Listeners | Category | Business | |||

本期《中国生物技术播客》聚焦康方生物的依沃西单抗将如何改写历史,以及在PD-(L)1/VEGF双抗之间是否即将发生国内头对头三期临床试验。
Could PD-(L)1/VEGF Agents Face Off First In China Phase III Trials?
Scrip Senior Writer Joseph Haas interviewed attorneys Kevin Cooper and Bill Roegge of Cooley LLP about recent events and trends in biopharmaceutical merger-and-acquisition activity. They discussed the current state of M&A after a busy conclusion to t... more
本期播客内容来自《Scrip》杂志,精选内容涵盖截至2026年4月17日当周的生物制药行业的商业动态。本期节目采用人工智能文本转语音及语音仿真技术制作。
本期要闻: Icotyde或将成为强生史上最重磅产品;daraxonrasib数据助力Revolution;Travere的Filspari成为首个用于治疗FSGS的药物;GSK重金押注B7-H4抗体药物偶联物;以及礼来夺得全球制药销售额榜首。
Story links: insights.citeline.com/scrip... more
Audio roundup of selected biopharma industry content from Scrip over the business week ended Apr. 17, 2026. This episode was produced with the help of AI text-to-voice and voice emulation tools.
This time – Icotyde could be J&J’s biggest ever produc... more
People also subscribe to these shows.





The guy needs to stop saying "um" and "uh" so much between his thoughts.
Can you please send your reporters to Toastmasters so they can focus on removing all the filler words Ahs and Hums form there speech! I can hardly listen to the episodes as one of your reporting says more filler words than real content.
Too many “uh” and broken sentences. I find it so painful to follow
Loved the Mithra episode - could be made better if audio quality was higher.
Often times a podcast with very good information, but quite poorly delivered. As someone who regularly conducts market research interviews via telephone and web, I’m very familiar with reading through far too many colloquialisms, filler words, and trite expressions. Words and phrases such as “right “and you know” “um” “and” “uh” make it painful to listen to in any regular basis.
Key themes from listener reviews, highlighting what works and what could be improved about the show.








Recent interactions between the hosts and their guests.
Listeners, social reach, demographics and more for this podcast.
| Listeners per Episode | |
|---|---|
| Gender Skew | |
| Location | |
| Interests | |
| Professions | |
| Age Range | |
| Household Income | |
| Social Media Reach |
Content primarily revolves around the biopharmaceutical and healthcare sectors, featuring insights on market trends, regulatory changes, and advancements in drug development and delivery. Discussions often center on recent news regarding pharma giants, emerging technologies, and evolving industry standards, presenting a comprehensive analysis of significant events impacting the landscape. The blend of interviews with industry professionals and detailed commentary on pressing issues offers listeners a nuanced understanding of the complexities faced by biopharma and medical device sectors.
Rephonic provides a wide range of podcast stats for Citeline Podcasts. We scanned the web and collated all of the information that we could find in our comprehensive podcast database. See how many people listen to Citeline Podcasts and access YouTube viewership numbers, download stats, audience demographics, chart rankings, ratings, reviews and more.
Rephonic provides a full set of podcast information for three million podcasts, including the number of listeners. View further listenership figures for Citeline Podcasts, including podcast download numbers and subscriber numbers, so you can make better decisions about which podcasts to sponsor or be a guest on. You will need to upgrade your account to access this premium data.
Rephonic provides comprehensive predictive audience data for Citeline Podcasts, including gender skew, age, country, political leaning, income, professions, education level, and interests. You can access these listener demographics by upgrading your account.
To see how many followers or subscribers Citeline Podcasts has on Spotify and other platforms such as Castbox and Podcast Addict, simply upgrade your account. You'll also find viewership figures for their YouTube channel if they have one.
These podcasts share a similar audience with Citeline Podcasts:
1. BioCentury This Week
2. The Readout Loud
3. Biotech Hangout
4. The Long Run with Luke Timmerman
5. Hard Fork
Citeline Podcasts launched 12 years ago and published 549 episodes to date. You can find more information about this podcast including rankings, audience demographics and engagement in our podcast database.
Our systems regularly scour the web to find email addresses and social media links for this podcast. We scanned the web and collated all of the contact information that we could find in our podcast database. But in the unlikely event that you can't find what you're looking for, our concierge service lets you request our research team to source better contacts for you.
Rephonic pulls ratings and reviews for Citeline Podcasts from multiple sources, including Spotify, Apple Podcasts, Castbox, and Podcast Addict.
View all the reviews in one place instead of visiting each platform individually and use this information to decide if a show is worth pitching or not.
Rephonic provides full transcripts for episodes of Citeline Podcasts. Search within each transcript for your keywords, whether they be topics, brands or people, and figure out if it's worth pitching as a guest or sponsor. You can even set-up alerts to get notified when your keywords are mentioned.
Recent guests on Citeline Podcasts include:
1. Mati Gill
2. Andy Parker
3. Alistair McDonald
4. Matt Simmons
5. Dr. Annette Bakker
6. Elizabeth Laws
7. Niraj Sharma
8. Bola Akinlade
To view more recent guests and their details, simply upgrade your Rephonic account. You'll also get access to a typical guest profile to help you decide if the show is worth pitching.